The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.
Dow Jones Top Company Headlines at 5 PM ET: Amazon Posts 13% Revenue Jump, Strong Cloud Sales | Apple ... The e-commerce giant said Amazon Web Services is growing at its fastest rate since 2022, ...
A $1 million Central Indiana Food Relief Fund has been launched to address the upcoming cuts to federal SNAP benefits due to ...
Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.
Investor's Business Daily on MSN
Eli Lilly Smashes Expectations In 'Arguably The Strongest Print' Of The Quarter
Eli Lilly stock rose early Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest ...
Walmart will offer in‑store pickup of Eli Lilly’s discounted weight‑loss drug Zepbound, giving self‑pay customers easier, ...
Metsera has become the obesity drug market's hottest ticket. The New York-based biotech is at the centre of a bidding war ...
Roblox posted a wider third-quarter loss but boosted its revenue forecast for the year as a pair of videogaming crazes generated robust top-line growth. Fox logged higher revenue in its fiscal first ...
NEW YORK (AP) — The U.S. stock market is pulling back from its record heights on Thursday, as Wall Street sifts through mixed ...
Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US ...
The restaurant chain posted a drop in net income and quarterly revenue missed forecasts. Chipotle said economic strains were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback